Author

Amaya Virós

University of ManchesterORCID 0000-0001-5177-5015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Martinez-Lopez· 1 shared Angeliki MalliriiD· 1 shared Arianna MarinelloiD· 1 shared Benjamin BesseiD· 1 shared Colin R. LindsayiD· 1 shared Fiona Helen BlackhalliD· 1 shared Heather A. WakeleeiD· 1 shared Helen AdderleyiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Martinez-Lopez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular CancerPeer-reviewedNov 12, 2024

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer

William J. McDaid, L. Wilson, Helen Adderley…·Angeliki Malliri

This study compares KRASG12C and KRASG12D mutant NSCLC models, finding that KRASG12D relies more on the PI3K-AKT-mTOR pathway, suggesting tailored combination therapies.

47 citationstop 3%

mousebulk RNA-seq

𝕏 PostBluesky